VJHemOnc is pleased to be a media partner for the 3rd European Research Initiative on CLL (ERIC) International Meeting, New Frontiers in CLL Research, which took place on 6-8 October 2022 in Barcelona, Spain, and gathered leading experts in CLL to discuss the most exciting updates in this field. Visit ericll2022.org to find out more about ERIC.
View all videos

ERIC 2022

The European Research Initiative on CLL 2022 Meeting
06–08 October 2022 | Barcelona, Spain

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Among the many things I am #thankful for: recent progress in hematologic malignancies. When I started my career - not that long ago! - standard therapy for myeloma was melphalan & prednisone or VMP, chlorambucil for CLL, CHOP (without R) for NHL, epoetin & transfusions for MDS./1

Joseph Scandura (@DrJoeScandura) of @WeillCornell shares some insights into the role of megakaryocytes in MPN pathophysiology:

👉http://ow.ly/C3R250LM7xn👈

#MPNCongress2022 #HemOnc #MPNsm @MeltonMedEd

🚨 Join us for another weekly podcast!

In this week's podcast, you will hear the latest updates in CLL with experts Nitin Jain & Catherine Coombs from #SOHO22!

🎧: http://ow.ly/yFeB50LNHqa

#CLLsm #LeuSM #HemOnc #ImmunoOnc

Load More...

ERIC 2022

The European Research Initiative on CLL 2022 Meeting
06–08 October 2022 | Barcelona, Spain
VJHemOnc is pleased to be a media partner for the 3rd European Research Initiative on CLL (ERIC) International Meeting, New Frontiers in CLL Research, which took place on 6-8 October 2022 in Barcelona, Spain, and gathered leading experts in CLL to discuss the most exciting updates in this field. Visit ericll2022.org to find out more about ERIC.
View all videos

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Among the many things I am #thankful for: recent progress in hematologic malignancies. When I started my career - not that long ago! - standard therapy for myeloma was melphalan & prednisone or VMP, chlorambucil for CLL, CHOP (without R) for NHL, epoetin & transfusions for MDS./1

Joseph Scandura (@DrJoeScandura) of @WeillCornell shares some insights into the role of megakaryocytes in MPN pathophysiology:

👉http://ow.ly/C3R250LM7xn👈

#MPNCongress2022 #HemOnc #MPNsm @MeltonMedEd

🚨 Join us for another weekly podcast!

In this week's podcast, you will hear the latest updates in CLL with experts Nitin Jain & Catherine Coombs from #SOHO22!

🎧: http://ow.ly/yFeB50LNHqa

#CLLsm #LeuSM #HemOnc #ImmunoOnc

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter